- Home
- STE
as 11-20-2024 4:00pm EST
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | DUBLIN |
| Market Cap: | 22.1B | IPO Year: | 1992 |
| Target Price: | $253.00 | AVG Volume (30 days): | 695.3K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.37 | EPS Growth: | -20.57 |
| 52 Week Low/High: | $195.47 - $248.24 | Next Earning Date: | 11-06-2024 |
| Revenue: | $5,325,525,000 | Revenue Growth: | 15.75% |
| Revenue Growth (this year): | 8.04% | Revenue Growth (next year): | 6.32% |
Stock Insider Trading Activity of STERIS plc (Ireland) (STE)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| TOKICH MICHAEL J | STE | Sr. Vice Pres., CFO | Sep 13 '24 | Sell | $245.79 | 23,332 | $5,714,642.92 | 42,930 | |
| TOKICH MICHAEL J | STE | Sr. Vice Pres., CFO | Sep 10 '24 | Sell | $247.00 | 23,332 | $5,763,004.00 | 42,930 |
Latest STERIS plc (Ireland) News
STE Breaking Stock News: Dive into STE Ticker-Specific Updates for Smart Investing
Argus Research
9 days ago
STE: Lowering target price to $234.00
Zacks
10 days ago
Why Steris (STE) International Revenue Trends Deserve Your Attention
MT Newswires
13 days ago
Wolfe Research Adjusts STERIS' Price Target to $265 From $250
Morningstar Research
13 days ago
Analyst Report: STERIS plc
GuruFocus.com
13 days ago
Steris PLC (STE) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid Margin Pressures
GuruFocus.com
13 days ago
Decoding Steris PLC (STE): A Strategic SWOT Insight
Thomson Reuters StreetEvents
13 days ago
Q2 2025 STERIS plc Earnings Call
GuruFocus.com
14 days ago
STERIS Shares Slide 4% Despite Strong EPS Beat and Growth in Key Segments
Compare STE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "STE STERIS plc (Ireland) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.